Thomas Spentzas

Dr. Thomas Spentzas

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
TSThomas Spentzas
Thomas Spentzas
JHJared Henricksen
Jared Henricksen
APAndrea B. Patters
Andrea B. Patters
ECEdward Chaum
Edward Chaum
To determine whether there was a correlation between tonometric measurements of the intraocular pressure and transducer measurements of the intracranial pressure in the acute setting, and whether intraocular pressure can be used as a surrogate measure of intracranial pressure. Children with traumatic brain injuries commonly develop increased intracranial pressure requiring surgical placement of a pressure transducer to measure the intracranial pressure during the acute recovery period. The increased intracranial pressure may cause engorgement of the orbital compartments via dilation of the episcleral veins and manifest as increased intraocular pressure. Prospective study. Tertiary academic pediatric intensive care unit. Children admitted with severe traumatic brain injury. Tonometric intraocular pressure measurements. We performed an Institutional Review Board-approved, prospective study on 36 children (age range, 2.9-15.1 yrs) with traumatic brain injuries, requiring intracranial pressure monitoring. A total of 274 intraocular pressure measurements were made after placement of the pressure transducer, and concordance between the sites of injury and measurement was documented. The average age of the patients was 8.3 yrs. The mean intraocular pressure, intracranial pressure difference was -0.5 +/- 0.68 cm H2O, and the variance was 29.88 (sd, 5.47). The 95% confidence interval was between -11.22 and 10.22. With concordance between the sites of measurement and injury, the mean IOP, intracranial pressure difference was -0.02 +/- 0.61 cm H2O (variance, 23.28; sd, 4.82; 95% confidence interval, - 9.47 to 9.42). Concordance reduced the variance of the intraocular pressure, intracranial pressure discrepancy by 20.3%. The Pearson intraocular pressure-intracranial pressure regression coefficient and the Krippendorff's alpha reliability estimate analyses indicated good agreement. The patient's age or Paco2 did not influence the intraocular pressure, intracranial pressure difference. Using 20 cm H2O as a normal intracranial pressure cutoff, the intraocular pressure had a specificity of 0.7 and sensitivity of 0.97; with concordance, the values improved to 0.78 and 0.96, respectively. Tonometry is a useful screening surrogate measure of intracranial pressure in children with traumatic brain injuries, but seems to lack the accuracy necessary for close management of intracranial pressure in the acute posttraumatic period.

17 June 2024 in Epilepsia
Verified
Journal Article
Closed access
NCNicolas Chiriboga
Nicolas Chiriboga
TSThomas Spentzas
Thomas Spentzas
RARenad Abu‐Sawwa
Renad Abu‐Sawwa

25 January 2011 in BMC Immunology
Verified
Journal Article
Open access
PDF file
TSThomas Spentzas
Thomas Spentzas
RSRebekah Kh Shapley
Rebekah Kh Shapley
CACarlos Acuna Aguirre
Carlos Acuna Aguirre
EMElizabeth Meals
Elizabeth Meals
LLLauren Lazar
Lauren Lazar
BEB Keith English
B Keith English
Infections caused by community-associated strains of methicillin-resistant Staphylococcus aureus (CA-MRSA) are associated with a marked and prolonged host inflammatory response. In a sepsis simulation model, we tested whether the anesthetic ketamine inhibits the macrophage TNF response to antibiotic-exposed CA-MRSA bacteria via its antagonism of N-methyl-D-aspartate (NMDA) receptors. RAW264.7 cells were stimulated for 18 hrs with 105 to 107 CFU/mL inocula of either of two prototypical CA-MRSA isolates, USA300 strain LAC and USA400 strain MW2, in the presence of either vancomycin or daptomycin. One hour before bacterial stimulation, ketamine was added with or without MK-801 (dizocilpine, a chemically unrelated non-competitive NMDA receptor antagonist), APV (D-2-amino-5-phosphono-valerate, a competitive NMDA receptor antagonist), NMDA, or combinations of these agents. Supernatants were collected and assayed for TNF concentration by ELISA.

9 October 2023 in Frontiers in Pediatrics
Verified
Journal Article
Open access
SASonya Hayes Armstrong
Sonya Hayes Armstrong
SGShantaveer Gangu
Shantaveer Gangu
AWAlina Nico West
Alina Nico West
TSThomas Spentzas
Thomas Spentzas
Introduction: The type of vascular access (central or peripheral) in pediatric critical care depends on several factors, including the duration of treatment, the properties of the medication (osmolarity or vesicant), and the need for central pressure monitoring. The utilization of peripheral intravascular catheters (PIVCs) has shown a notable increase in the number of patients being treated. Extended dwell or midline catheters are another peripheral access option in addition to PIVCs. However, there are currently no established guidelines on their placement.Objectives: The aim of this study is to estimate the duration of dwell time for PIVCs, analyze the specific parameters affecting it, and develop recommendations for switching to extended dwell and midline catheter placement as an alternative to peripheral access.Methods: The study enrolled patients aged 0–18 years admitted to the pediatric intensive care unit (PICU) for over 24 h and managed with peripheral access only over 2 years (2019–2021).Measurements and main results: A total of 484 patients met the specified criteria. Patients who had peripheral access exhibited a lower PRISM score and a shorter length of stay in the PICU, with mean values of 18 (SD: 8.5) and 9.5 (SD: 6.4) days, respectively, compared with patients who had central access with mean values of 8.9 (SD: 5.9) and 5.7 (SD: 3.6) days, respectively. The PIVC dwell time was found to be 50.1 h (SD: 65.3) and required an average of 1.6 insertion attempts. Patients with three or more insertions exhibited an increased odds ratio of 5.2 (95% CI: 3.1–8.5) for receiving an extended dwell or midline insertion. Increased dwell time was associated with female gender, 59.5 h (P < 0.001), first attempt insertion, 53.5 h (P < 0.001), use of 24 Ga bore, 56.3 h (P = 0.04), left-sided insertions, 54.9 (P = 0.07), less agitation, 54.8 h (P = 0.02), and less edema, 61.6 (P < 0.001). Decreased dwell time was associated with the use of vancomycin infusion at 24.2 h (P < 0.001) and blood transfusions at 29.3 h (P < 0.001).Conclusions: Extended catheters last longer than PIVCs in PICU patients. Extended catheter placement requires consideration of the length of treatment, as well as the overall body edema, the level of the patient's restlessness, and the need for vancomycin infusion or blood transfusions, as these factors reduce PIVC dwell time and expose the patients to painful insertions. For such cases, an extended dwell catheter may be a better option, even if the projected treatment time is less than 6 days.

20 October 2010 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
SSShah Samir
Shah Samir
YCYeung Colin
Yeung Colin
TSThomas Spentzas
Thomas Spentzas

10 October 2012 in International Journal of Inflammation
Verified
Journal Article
Open access
PDF file
TSThomas Spentzas
Thomas Spentzas
RSRebekah K. H. Shappley
Rebekah K. H. Shappley
FSFabio Savorgnan
Fabio Savorgnan
EMElizabeth Meals
Elizabeth Meals
BEB. Keith English
B. Keith English
Background. Methicillin-resistantStaphylococcus aureus(MRSA) can stimulate massive cytokine release. Ketamine suppresses tumor necrosis factor (TNF) secretion by MRSA-stimulated RAW264.7 macrophages, and the mechanism likely involves N-methyl-D-aspartic acid (NMDA) receptor antagonism. The downstream effects of NMDA-mediated TNF suppression, specifically the PI3K/Akt and mTOR modulation, have not been described.Methods. RAW264.7 cells were stimulated for 18 hrs with 105to 107 CFU/mL inocula of either of two prototypical community-acquired- (CA-) MRSA isolates, USA300 strain LAC and USA400 strain MW2. Then we added the NMDA inhibitors ketamine or 2R-amino-5-phosphonopentanoate (AP5), NMDA substrate, LY294002, and rapamycin in various combinations.Results. NMDA inhibition suppressed TNF secretion by almost a third compared to the no-ketamine control. When NMDA substrate was added, the TNF secretion increased by 10%. Addition of LY294002 suppressed TNF production by macrophages by 20%. Rapamycin exhibited a concentration-dependent TNF induction-suppression response: induction at doses of 0.1 and 1 ng/mL and suppression at 10 and 100 ng/mL. Induction of TNF was abolished when LY294002 was added and the suppression became uniform. Ketamine-induced suppression of TNF secretion was intensified 10–15% when rapamycin was added, but not when LY294002 was added.Conclusion. These findings suggest that NMDA-induced TNF suppression can be augmented by concurrent mTOR inhibition.